Business
Bruker Announces Collaborative Advances in CCS-Enabled 4D Proteomics Workflows at HUPO
Co-marketing agreement with Cellenion on cellenONE® sample preparation system for automated label-free workflows for single-cell 4D proteomics on timsTOF SCP
About this update from Bruker Corporation
[{"type":"text","content":"\n\nCo-marketing agreement with Cellenion on cellenONE® sample preparation system for automated label-free workflows for single-cell 4D proteomics on timsTOF SCP\n\n\nSeer Proteograph™ Product Suite combined with timsTOF Pro 2 and timsTOF SCP enables, deep, unbiased, rapid detection of >3000 protein groups from human plasma\n\n\nCo-marketing new PreOmics BeatBox for high-throughput, high-performance tissue, biopsy and cell culture homogenization prior to enzymatic digestion and timsTOF 4D proteomics\n\n\n BILLERICA, Mass.--(BUSINESS WIRE)--\nAt the virtual 20th Human Proteome Organization World Congress, HUPO Reconnect 2021 (hupo2021.org) Bruker Corporation (Nasdaq: BRKR) announced major advances in collision cross section (CCS) enabled 4D proteomics workflows on the unique timsTOF multiomics platform.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211116005569/en/cellenONE - Isolate 96 single cells in a few minutes. (Photo: Business Wire)\nDr. Gary Kruppa, Bruker’s Vice President for Proteomics, stated: “Widespread adoption of proteomics has been limited by complex sample preparation protocols that were not easily automated. We are excited to announce that Bruker is collaborating with industry-leading partners on higher performance, automated workflows in three key areas: single-cell proteomics, plasma proteomics and tissue proteomics.”\n\nA. New Collaboration with Cellenion for 4D Single-Cell Proteomics (SCP)\n\nBruker announces a co-marketing agreement with Cellenion on the cellenONE single-cell isolation and nanoliter dispensing robotic platform. The partnership with Cellenion on label-free 4D single-cell proteomics (SCP) provides timsTOF SCP users with an end-to-end solution. The cellenONE is a unique single-cell isolation and nanoliter dispensing technology. It enables high-throughput, automated dispensing of individual cells from cell suspensions with its unique advantage of minimal perturbation to the integrity of the live cell. It is also perfectly suited for reagent dispensing, enabling miniaturized sample preparation protocols on those isolated cells.\n\nDr. Holger Eickhoff, CEO of Cellenion and Scienion, said: “We believe our expertise in precision dispensing and platform technology for up to 100% single-cell isolation accuracy and Bruker’s expertise in d...